(HealthDay News) – A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers. The monoclonal antibody shot would protect against respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, the New York Times reported. It could also…  read on >  read on >

The percentage of cancer survivors who struggle with a disability has doubled in the past 20 years, new research shows. “The fact that we are saving more lives from cancer is worth celebrating, but it also warrants a shift toward understanding and improving the quality of life for those who survive,” said study co-author Dr.…  read on >  read on >

Astronauts spending six months or longer in space should stretch their time between trips to three years, warns new research on the impact of space travel on the brain. To study this, researchers examined the brain scans of 30 astronauts, looking at scans that depicted their brains both before and after their missions. The research…  read on >  read on >

After three hours of surgery on Wednesday, Pope Francis was recovering at Gemelli hospital in Rome on Thursday. Pope Francis had a hernia in his abdominal wall repaired, along with the removal of scar tissue in his intestine that had created a partial blockage and was causing him pain, the Associated Press reported. Doctors placed…  read on >  read on >

A new transplant method that “reanimates” donor hearts appears safe and effective, a new clinical trial has found — in an advance that could substantially expand the supply of donor hearts available in the United States. The trial tested an approach that allows doctors to transplant hearts from donors who have succumbed to “circulatory death”…  read on >  read on >

(HealthDay News) – A new survey of cancer centers find that chemotherapy shortages are affecting most of them, prompting last-minute changes in treatment for numerous types of cancer. About 93% of the centers surveyed said they were experiencing shortages of the drug carboplatin, while 70% were short on cisplatin. Together, these platinum chemotherapies can treat…  read on >  read on >